H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH
2024 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-024-75458-2
J
Jonathan S. Rodríguez-Sanabria
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
111
Citations
5
h-index
3
i10-index
Jonathan S. Rodríguez-Sanabria is an academic researcher from Universidad de Guadalajara. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & MicroRNA in disease regulation & Epigenetics and DNA Methylation. The author has an h-index of 5, co-authored 10 publications.
Papers by this author
worksMexMix supplementation prevented MAFLD development by restoring microbiota-gut-liver axis in a mice model.
2024 · Annals of Hepatology · 0 citations
https://doi.org/10.1016/j.aohep.2024.101465
Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel
2024 · Annals of Hepatology · 0 citations
https://doi.org/10.1016/j.aohep.2024.101407
Pirfenidone Prevents Myocarditis by Restoring Metabolic Hormone Levels in a Mouse MASH Model and its Effect on H9c2 Myoblast Viability under Glucolipotoxicity
2025 · Annals of Hepatology · 0 citations
https://doi.org/10.1016/j.aohep.2025.101843
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat